The reduced IL-10 production by B cells observed in RRMS and SPMS patients may therefore be attributed to another B cell phenotype, including IL-10-producing regulatory B cells or ASC (9, 114). This evidence concerns the gene IL10 and secondary progressive multiple sclerosis.